News

Now, researchers from Kyushu University have revealed that the smallest known protein-based tRNA-processing enzyme, called ...
To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...
To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...
Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...
Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...
Ribosomes are tiny molecular machines inside all living cells that build proteins, and ribosome biogenesis is the complex, ...
The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has singled it out for scrutiny, clouding its prospects.
About Hanson Wade Group - 3rd mRNA Process Development & Manufacturing Europe The mRNA market is projected to reach $63.28 billion by 2025, indicating an all-time high global demand for mRNA ...
Researchers have discovered a process that breaks down mRNA molecules in the human body particularly efficiently. This could be useful, for example, in the treatment of cancer.
So the new mRNA may need to strike just the right balance of VEGF. The study team now plans to test whether the new therapy is safe and effective in larger animals — namely, non-human primates.
3 rd Annual mRNA Process Development & Manufacturing Summit - members of Applied DNA's Biotherapeutics Sales and Business Development teams (collectively 'LineaRx,' a majority-owned Applied DNA ...